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Abstract Anaphylatoxins (C5a and C3a), which are generated 
during complement activation, have recently been shown to 
increase glucose output from hepatocytes (HC) in perfused rat 
liver. They did not act directly on HC but indirectly by 
prostanoid release from non-parenchymal cells (NPC), probably 
Kupffer cells (KC). In order to corroborate this mechanism, the 
distribution of anaphylatoxin receptors in the different cell types 
of rat liver was determined by quantitative RT-PCR with primers 
specific for the rat C5a receptor (rC5aR) using RNA isolated 
from KC, sinusoidal endothelial cells (SEC), hepatic stellate cells 
(HSC) and HC. In line with functional data, C5aR mRNA was 
detected in freshly isolated NPC but not in HC of rat liver. 
Mainly KC but also HSC clearly expressed C5aR mRNA, while 
SEC did so only weakly. KC expressed up to 10-fold more C5aR 
mRNA than HSC and these in turn up to 10-fold more than 
SEC. These results support the proposed indirect action of 
anaphylatoxins on HC. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The anaphylatoxin C5a is generated by specific limited pro-
teolysis of complement protein C5 during complement activa-
tion via the classical or the alternative pathway. It is a small 
diffusible glycopeptide derived from the first 74 (man) or 77 
(rat) amino acid residues of the C5a-chain [l^t]. C5a acts as a 
potent inflammatory mediator by causing the degranulation 
of mast cells, the contraction of smooth muscle cells, an in-
crease in vascular permeability and the chemotaxis and acti-
vation of neutrophils, resulting in the immigration of the cells 
into the inflamed tissue and the local release of reactive oxy-
gen species, eicosanoids and cytokines [reviewed in [5-8]]. The 
effects of C5a are mediated via a high affinity C5a receptor 
(C5aR) which in man has been characterized as a 40-48 kDa 
membrane protein, which belongs to the 7-transmembrane 
domain receptor family and is coupled to the a-subunit of a 
pertussis toxin-sensitive G-protein [9,10]. Also sequences of 
the dog [11], mouse [12] and partial sequences of the bovine 
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[11] and rat C5a receptors [11] have been cloned. The entire 
coding sequence of the rat C5aR has recently been communi-
cated [Rothermel, E., Zwirner, J., Rabini, S. and Gotze, O., in 
preparation, GenBank accession number Y09613]. 
In rat liver, anaphylatoxins have recently been shown to 
influence glucose metabolism and hemodynamics [13-15], 
The enhanced glucose output and reduced flow elicited by 
recombinant rat C5a (rrC5a) in perfused rat liver were accom-
panied by an overflow of prostanoids [14,15] and largely pre-
vented by the prostanoid synthesis inhibitor indomethacin 
[14]. Moreover, they were clearly reduced in livers in which 
the Kupffer cells (KC) — the resident macrophages of the liver 
— had been selectively eliminated by pretreatment with gado-
linium chloride [15]. These results indicated that the rrC5a-
induced metabolic and hemodynamic effects were at least in 
part mediated by prostanoids released from KC. In line with 
these observations rrC5a induced a time- and dose-dependent 
release of prostaglandins and thromboxane in KC cultures 
and led to the activation of glycogen phosphorylase in KC/ 
hepatocyte (HC) cocultures but not in HC cultures alone [16]. 
Again, this effect was completely suppressed by inhibition of 
prostanoid synthesis [16]. Apparently, rrC5a did not act di-
rectly on HC but indirectly via prostanoids released from KC. 
This proposed mechanism might be at variance with the re-
ported presence of C5aR on HC in human liver [17,18]. 
Therefore, the expression of mRNA for the C5aR was inves-
tigated in rat HC and KC and in other non-parenchymal cells 
(NPC), i.e. sinusoidal endothelial cells (SEC) and hepatic stel-
late cells (HSC) from rat liver. 
2. Materials and methods 
2.1. Animals 
Male Wistar rats (Winkelmann, Borchen, Germany, 350-450 g for 
the isolation of KC, SEC and HSC, 200-250 g for HC) were kept on a 
12 h day/night rhythm with free access to water and a standard rat 
diet (Ssniff, Soest, Germany). 
2.2. Cell preparation 
HC were isolated by collagenase digestion or alternatively accord-
ing to Meredith without the use of collagenase [19]. Briefly, the liver 
was perfused at 37°C in a non-recirculating manner via the portal vein 
with a Ca2+-free Krebs-Henseleit buffer containing 15 mM glucose, 
2 mM lactate, 0.2 mM pyruvate and 2 mM EDTA. The flow rate was 
10 ml/min. After 45 min the liver was exised, the liver capsule was 
opened and hepatocytes were suspended in Krebs-Henseleit buffer 
containing 1 mM CaCl2 and filtered through nylon gauze (mesh di-
ameter 60 urn). Detritus was removed by two subsequent washing 
steps at 50 g and viable HC were further purified through a 58% 
Percoll gradient. Purity of hepatocytes as identified on the basis of 
their typical light microscopic appearance was greater than 95%. 
0014-5793/97/517.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793(97)00292-5 
306 H.L. Schieferdecker et al.lFEBS Letters 406 (1997) 305-309 
KC and SEC were prepared by a combined collagenase/pronase 
perfusion and were purified by Nycodenz density gradient centrifuga-
tion and subsequent centrifugal elutriation using a Beckman JE-6 
elutriation rotor in a J-21 Beckman centrifuge [20,21]. 
HSC were obtained by enzymatic digestion of the liver essentially as 
described in [22] with some modifications [N. Kawada, personally 
communicated]. The resulting cell suspension, subsequently handled 
at 4°C, was filtered through nylon gauze (mesh diameter 60 urn) and 
centrifuged for 10 min at 450 g. After two washing steps, cell sedi-
ments were resuspended in Hanks' Balanced Salt Solution (HBSS), 
mixed with Nycodenz to a final concentration of 8.13% and overlaid 
with HBSS. After centrifugation for 20 min at 1400Xg HSC were 
obtained from the interphase. Purity of HSC as identified on the basis 
of their typical light microscopic appearance was about 95%. 
2.3. RNA isolation and cDNA synthesis by reverse transcription 
Total RNA from freshly isolated KC, HSC, SEC and HC was 
isolated either by homogenization in guanidine thiocyanate followed 
by cesium chloride gradient ultracentrifugation [23] or by an RNeasy 
Kit provided by Qiagen (Hilden, Germany). Total RNA (6 |ig) was 
preincubated for 10 min at 68°C with 500 ng oligo-d(T)i2-is and 
transcribed with reverse transcriptase (RT) (Superscript II, Gibco, 
Eggenstein, Germany) into cDNA. In some cases the efficiency of 
the cDNA synthesis was monitored by reverse transcription in the 
presence of [35S]dATP (1000 Ci/mmol, ICN Pharmaceuticals, Esch-
wege, Germany) [24]. The cDNA thus generated was precipitated with 
ammonium acetate/ethanol in order to remove unincorporated radio-
activity, washed 3 times with 70% ethanol and resuspended in deion-
ized H2O. The radioactivity incorporated into the cDNAs was as-
sumed to be proportional to the amount of newly synthesized 
cDNAs [24]. 
2.4. Polymerase chain reaction 
Equal amounts of cDNA from total RNA of KC, HSC, SEC and 
HC were amplified in a 50 jj.1 reaction mix containing 1.5 mM MgCl2, 
0.6 uM of foreward and reverse oligonucleotide primers rC5aR-Fl 
and -R2, degC5aR-F3 and -R4, rP-actin-F and -R, hp-actin-F and 
-R (Table 1) or 0.1 uM primers for human C5aR (hC5aR, Stratagene, 
Heidelberg, Germany), 0.2 mM dNTPs, 6% DMSO and 0.5 U of 
thermostable DNA polymerase (Goldstar Red, Eurogentec, Seraing, 
Belgium). PCR reactions were prepared as master mixes before the 
addition of the respective cDNAs. The cDNA was denatured for 3 min 
at 94°C and then subjected to 35 cycles of 1 min at 94°C, 1 min at 
58°C (rC5aR, degC5aR and hp-actin), 61 °C (rP-actin) or 60°C 
(hC5aR), and 2 min at 72°C with a final elongation step of 10 min 
at 72°C. After amplification, polymerase chain reaction (PCR) prod-
ucts were separated in 2% agarose gels and visualized by ethidium 
bromide staining. The rC5aR product amplified from KC was cloned 
with SureClone ligation kit (Pharmacia, Freiburg, Germany) into 
pUC 18 and sequenced for identification using dyedeoxy terminator 
NTPs (Perkin Elmer, Weiterstadt, Germany). 
2.5. Generation of the internal standard for the rC5aR 
The rat C5aR cDNA was isolated using a hybridization probe 
produced by PCR with degenerate primers corresponding to con-
served parts of the published C5aR sequences [Rothermel, E., Zwir-
ner, J., Rabini, S. and Gotze, O., in preparation, GenBank accession 
number Y09613], A 678 bp Hindi fragment of the cloned rC5aR 
sequence was cloned into the Hindi restriction site of pBlueScript 
KS II. From this construct a 148 bp fragment was removed by re-
striction enzyme digestion with Avail (Gibco, Eggenstein, Germany) 
at positions 568 and 716 (GenBank accession number Y09613), fol-
lowed by gel electrophoresis, gel extraction (QIAquick gel extraction 
kit, Qiagen, Hilden, Germany) and religation with T4 Ligase (Gibco). 
The shortened insert ('internal standard') was isolated by restriction 
enzyme digestion of the flanking polylinker region with Xhol (MBI 
Fermentas, St. Leon-Rot, Germany) and EcoRl (Boehringer-Mann-
heim, Mannheim, Germany) and purified by agarose gel electropho-
resis and extraction as described above. 
2.6. Quantitative RT-PCRfor C5aR cDNA 
For quantitative PCR, a constant amount of KC-, HSC- or SEC-
cDNA was co-amplified with the internal standard in 10-fold dilution 
steps under the conditions described above. After amplification, PCR 
products were separated in 2% agarose gels and visualized by ethidi-
um bromide staining. 
3. Results 
3.1. Detection of rat C5a receptor mRNA in Kupjfer, stellate 
and in sinusoidal endothelial cells but not in hepatocytes of 
rat liver 
To investigate the expression of C5aR m R N A in different 
cell types of rat liver, equal amounts of R N A isolated from 
K C , HSC, SEC and H C were submitted to reverse transcrip-
tion and PCR with primers specific for rC5aR and rp-actin 
( rC5aR-Fl and rC5aR-R2; rP-actin-F and rP-actin-R, Table 
1). P C R amplification yielded a single product corresponding 
to the expected 511 bp. With the cDNAs derived from K C 
and H S C product formation was strong and with the c D N A 
from SEC it was weak. N o product was obtained with the 
c D N A from H C (Fig. 1). The identity of the amplified prod-
uct was verified by cloning and sequencing the P C R product 
derived from the K C c D N A (data not shown). 
The differences in C5aR m R N A expression observed in the 
different cell types were not due to differences in the efficien-
cies of c D N A synthesis, since all cell types expressed similar 
amounts of p-actin m R N A (Fig. 1). Moreover, the same re-
sults were obtained when reverse transcription was performed 
in the presence of [35S]dATP to monitor the efficiency of 
c D N A synthesis and when equal amounts of radioactive 
c D N A were analysed (data not shown). The finding that hep-
atocytes did not express C5aR m R N A was independent from 
the kind of isolation procedure both for the cells and for 
R N A (see Section 2). 
3.2. Detection of C5a receptor mRNA with degenerate primers 
in the human hepatoma cell line HepG2 and rat Kupffer 
cells but not rat hepatocytes 
The human hepatocellular carcinoma cell line HepG2 has 
Table 1 
Oligonucleotide primers used for RT-PCR 
Name Sequence (5'->3') GenBank accession No Position 
rC5aR-Fl 
rC5aR-R2 
degC5aR-F3 
degC5aR-R4 
rP-actin-F 
rP-actin-R 
hp-actin-F 
hP-actin-R 
GGT GGC CGA CCT CCT CTC GTG 
GAC CAC CGC CAT CAC CAC TTT G 
CTC ATC/T CTG CTC AA
C/T ATG TA 
CAC CAC C/TTT GAG
 C /TGT
 C/TTT GG 
GAT ATC GCT GCG CTC GTC GTC 
CCT CGG GGC ATC GGA ACC 
CCC AGC CAT GTA CGT TGC TAT 
GGG TGG CTT TTA GGA TGG CAA 
Y09613 
X57250 
Y09613 
J00691 
HSAC07 
: are printed in bold face. 
267- 287 
777- 756 
343- 362 
732- 713 
373- 392 
765- 746 
1251-1271 
2570-2553 
428- 448 
1474-1454 
In the rat C5a receptor primers (rC5aR-Fl, 
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previously been shown to express C5aR mRNA [25]. Since it 
was not possible to detect C5aR mRNA in HepG2 cells with 
the rat primers used (rC5aR-Fl, rC5aR-R2; Table 1; Fig. 2) 
control PCR with degenerate primers for C5aR (degC5aR-F3, 
degC5aR-R4; Table 1) binding in an area of high homology 
between the human and the rat sequence was performed. Also 
with this primer pair C5aR was detected in rat KC but not in 
rat HC. As expected these primers revealed C5aR mRNA 
expression also in HepG2 cells (Fig. 2). Moreover, the human 
primers originally employed for the detection of C5aR mRNA 
in HepG2 cells [25] cross-reacted with the rat sequence, thus 
yielding a product again in HepG2 cells and rat KC but not 
rat HC (data not shown). 
3.3. Quantification of mRNA for the rat C5a receptor in 
Kupffer, hepatic stellate and sinusoidal endothelial cells 
by quantitative RT-PCR 
Rat KC and HSC strongly expressed C5aR mRNA whereas 
SEC did so only weakly (Fig. 1). In order to quantitate C5aR 
mRNA expression in the different cell types, PCR was per-
formed with cDNAs derived from KC, HSC and SEC in the 
presence of an internal C5aR cDNA standard shortened by 
148 bp. When equal amounts of cDNA were amplified in the 
presence of decreasing amounts of the internal standard 
(6000-0.006 amol), both competed for the oligonucleotide pri-
mers according to their molar ratio in the reaction mixture 
(Fig. 3). At high molar excesses of either internal standard or 
cell-derived cDNA, essentially only standard or cDNA were 
amplified by PCR, while both products were formed in equal 
intensity when present in equimolar amounts (Fig. 3). By 
determining the amount of internal standard that resulted in 
the same quantity of PCR product as cell-derived cDNA, the 
amount of C5aR cDNA per ug RNA could be determined. 
For example, when 6 ug RNA were reverse transcribed in a 
volume of 20 u.1 and subsequently 1 ul of a 1:10 dilution of 
this cDNA was coamplified with different dilutions of the 
internal standard, in case of equimolarity of cDNA and in-
ternal standard at 6 amol standard this corresponded to 200 
amol C5aR cDNA/ug total RNA. For KC the amount of 
cDNA thus was evaluated as 200 amol C5aR cDNA/ug total 
RNA in three different experiments. For HSC up to 10-fold 
and for SEC 10- to 100-fold lower expression levels were 
detected, whereas for HC the amount of cDNA was always 
I 
Fig. 1. Detection of mRNA for the C5a receptor in Kupffer (KC), 
stellate (HSC) and sinusoidal endothelial cells (SEC) but not hepa-
tocytes (HC) of rat liver by RT-PCR (rat primers). cDNA was gen-
erated by reverse transcription of equal amounts of total RNA 
from the different cell types and subjected to 35 cycles of PCR in 
the presence of sequence specific primers for the rat C5a receptor 
(primers rC5aR-Fl and rC5aR-R2, 511 bp) and r(3-actin (primers 
rp-actin-F and rp-actin-R, 769 bp). 
Fig. 2. Detection of mRNA for the C5a receptor in HepG2 cells 
and rat Kupffer cells (KC) but not rat hepatocytes (HC) by RT-
PCR with degenerate primers. cDNA was generated by reverse tran-
scription of equal amounts of total RNA from the different cell 
types and subjected to 35 cycles of PCR in the presence of degener-
ate primers for the human and rat C5a receptor (primers degC5aR-
F3 and degC5aR-R4, 390 bp and 393 bp, respectively) and with se-
quence specific primers for the rat C5a receptor (see Fig. 1). *P-ac-
tin-mRNA was detected in rat KC and HC with primers rP-actin-F 
and -R (see Fig. 1) and in HepG2 cells with primers hp-actin-F and 
-R (1047 bp). 
below the detection limit of 0.2 amol C5aR cDNA/ug total 
RNA (three experiments, each) (Table 2). 
4. Discussion 
C5aR mRNA expression was investigated in hepatocytes 
(HC), Kupffer cells (KC), hepatic stellate cells (HSC) and 
sinusoidal endothelial cells (SEC) of rat liver by means of 
quantitative RT-PCR. This technique was chosen, because a 
low abundance of mRNA for C5aR was expected at least in 
some cell types of the liver: in a recent study investigating the 
expression of the C5aR in human liver and lung, only a weak 
expression of C5aR mRNA could be detected in RNA ex-
tracted from whole liver by Northern blot analysis [17]. As 
expected, cDNAs derived from equal amounts of total RNA 
from KC, HSC, SEC and HC of rat liver showed clear differ-
ences in the expression of C5aR mRNA (Fig. 1, Table 2). 
4.1. Expression of C5aR mRNA in Kupffer cells but not in 
hepatocytes of rat liver 
The liver might be confronted with anaphylatoxins gener-
ated by complement activation both systemically reaching the 
liver via the portal vein and locally in the liver tissue itself. 
Alternatively, active proteases formed during blood clotting 
or other serine hydrolases of tissue or leukocyte origin can 
result in the localized production of C5a at sites of local injury 
[26]. C5aR mRNA was strongly expressed in KC but not at 
all in HC (Fig. 1). These results are consistent with the recent 
findings that anaphylatoxins increased glucose output in per-
fused rat liver and in KC/HC cocultures via prostanoids re-
leased from KC [13-16]. They are also in accord with the 
observation that C5aR so far have been found predominantly 
on cells of myeloid origin such as neutrophils, eosinophils, 
monocytes, macrophages and the myeloid cell lines U937 
and HL-60. The lack of C5aR mRNA in HC of rat liver — 
although in correspondence with functional data — is in con-
trast to recent studies in the human system in which the de-
tection of C5aR mRNA by in situ hybridisation of human 
liver tissue was interpreted as expression of C5aR mRNA in 
HC [17,18]. This divergence might be due either to differences 
in the methodologic approach including interpretation of re-
sults or to genuine species differences between man and rat. 
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Fig. 3. Quantification of cDNA for the C5a receptor in rat KC by competitive PCR. Equal amounts of KC-cDNA derived from 6 |ig total 
RNA were coamplified with 10-fold dilution steps of the internal standard ranging from 6000 to 0.006 amol (PCR products: 511 bp (cDNA) 
and 363 bp (internal standard)). The arrow denotes the point of equimolarity between cell-derived cDNA and internal standard. 
The presumed expression of C5aR mRNA in human HC was 
supported by the detection of C5aR mRNA in the human 
hepatoma cell line HepG2 [25,17]. Using degenerate primers 
(Table 1) and the same human primer pair as in the original 
study [25] C5aR mRNA could be detected in HepG2 cells and 
in rat KC but not in rat HC (Fig. 2 and data not shown). 
Again, this difference between human hepatoma and rat hep-
atocytes might be due to species differences or to malignant 
transformation. Therefore, the possibility has to be considered 
that acute and/or chronic inflammation could induce C5aR 
mRNA expression also in rat HC. 
4.2. Expression of C5aR mRNA in hepatic stellate cells 
C5aR mRNA was also expressed in HSC although less 
strongly than in KC (Fig. 1, Table 2). HSC can clearly be 
differentiated from SEC and KC on the basis of their typical 
light microscopic appearance due to intracytoplasmatic vita-
min A droplets. The cell preparations were microscopically 
pure; thus, minor contaminations with other non-parenchy-
mal cells (i.e. a mixture of KC and SEC) can hardly explain 
the strong expression of C5aR mRNA in these cells. HSC 
(Ito-, fat-storing- or perisinusoidal cells) have great similarities 
with smooth muscle-like pericytes in other organs concerning 
morphology, physiology and pathophysiology [27]. Activation 
of HSC results in proliferation and transformation into 'myo-
fibroblast-like' cells, a process which is accompanied by the 
expression of cc-smooth muscle actin [28] which plays a key 
role in contraction processes. Several studies have demon-
strated that isolated cultured HSC contract in response to 
various vasoconstricting stimuli such as prostaglandin F2a, 
thromboxane, thrombin, angiotensin-II, endothelin, and sub-
stance P [22,29-32]. Also C5a has vasoactive capacities and 
causes smooth muscle contraction [33,34]. Thus, the most 
probable function of C5aR expression on HSC might be the 
mediation of cell contraction resulting in a reduced blood flow 
and thereby facilitating the immigration of inflammatory cells 
into the liver tissue. Consequently, the portion of flow reduc-
tion observed after stimulation with rrC5a in perfused rat liver 
which was not inhibitable by the prostanoid synthesis inhib-
itor indomethacin or the thromboxane receptor antagonist 
daltroban (37% and 19%, respectively, [14]) might have been 
due to HSC contraction induced directly by rrC5a. However, 
until now contraction of HSC has only been demonstrated for 
cultured cells resembling 'activated' myofibroblast-like cells 
rather than quiescent HSC. Therefore it has to be investi-
gated, whether cell contraction can be induced by rrC5a in 
short-term cultures of HSC and whether prolonged culture of 
these cells leads to alterations in C5aR expression and possi-
bly in their capacity to contract in response to C5a. 
4.3. Weak expression of C5aR mRNA in sinusoidal endothelial 
cells 
Besides KC and HSC also SEC weakly expressed C5aR 
mRNA (Fig. 1, Table 2). While cultured KC and SEC can 
be differentiated based on their capacity to phagocytose latex 
particles of different diameters or by expression of cell specific 
surface antigens, these parameters cannot be tested with 
freshly isolated KC and SEC. Due to the pronase/collagenase 
digestion necessary for the isolation of non-parenchymal cells 
surface structures required for phagocytosis and some surface 
markers have been lost. SEC cultured for 48 h contain about 
5% KC (own data, not shown). Thus, the weak C5aR mRNA 
expression in SEC (Fig. 1), which by quantitative RT-PCR 
has been shown to represent only 1 to 10% of C5aR cDNA 
found in KC (Table 2) might be due to contamination of SEC 
with KC. Nevertheless, it cannot be excluded from these ex-
Table 2 
Quantification of C5a receptor cDNA in Kupffer-, hepatic stellate-, sinusoidal endothelial cells and hepatocytes of rat liver by means of com-
petitive RT-PCR 
Cell type C5aR cDNA 
(amol/ug total RNA) 
C5aR 
Kupffer cells 
Hepatic stellate cells 
Sinusoidal endothelial cells 
Hepatocytes 
200 
20-200 
2-20 
<0.2 
++++ 
+++ 
+ ? 
Values are from three experiments each: ?, low level expression or contamination. 
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periments that also SEC themselves weakly express C5aR 
m R N A . In human umbilical vein and rat pulmonary artery 
endothelial cells, C5a has been shown to activate protein kin-
ase C and generate inositol-l,4,5-trisphosphate, to produce 
O 2 " radical and to convert xanthine dehydrogenase to xan-
thine oxidase [35,36]. Moreover, in a recent study demonstrat-
ing the induction of P-selectin expression in human umbilical 
vein endothelial cells by C5a [37], C5aR expression was also 
shown by R T-PC R and by the demonstrat ion of specific bind-
ing of [125I]C5a to these cells. Also in this case only a rather 
low number of binding sites — i.e. 10% of the number bound 
to human neutrophils — could be detected. Another indirect 
hint that also SEC might express C5aR m R N A could be that 
SEC together with K C belong to the reticulohistiocytotic sys-
tem representing the totality of mesenchymal cells with phago-
cytotic capacity in the body. Binding studies and functional 
data have to show whether SEC from rat liver express C5a 
receptors. 
5. Conclusions 
In the present study C5a receptor m R N A expression was 
investigated for the first time in freshly isolated parenchymal 
and non-parenchymal liver cells rather than in whole liver or 
in the malignant cell line HepG2. Kupffer and stellate cells 
strongly expressed C5a receptor m R N A , whereas sinusoidal 
endothelial cells contained 10-100-fold less C5a receptor 
m R N A than Kupffer cells. Hepatocytes were devoid of C5a 
receptor m R N A . This receptor distribution is in line with the 
proposed indirect mechanism of action of the anaphylatoxin 
C5a on liver metabolism via Kupffer cell derived prostanoids. 
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